Sunshine Biopharma Inc (SBFM)

[EOT]

1-20 is nothing but a way to move up to QB.

If they did uplist then they would need “beginning trials news” to sustain the QB. Or yes it would drop back down.

The $10mil funding prerequisite was QB.
So my thoughts are...

R/S. Uplist to QB. Get $10mil funding,
Then announce “trials beginning” and the stock flies$



FROM THE Q........

“We have been delayed in our clinical development program due to lack of funding. Our fund raising efforts are continuing and as soon as adequate financing is in place we will continue our clinical development program of Adva-27a by conducting the following next sequence of steps:

? GMP Manufacturing of 2 kilogram for use in IND-Enabling Studies and Phase I Clinical Trials

? IND-Enabling Studies

? Regulatory Filing (Fast-Track Status Anticipated)

? Phase I Clinical Trials (Pancreatic Cancer Indication)

Adva-27a’s initial indication will be Pancreatic Cancer for which there are currently little or no treatment options available. We are planning to conduct our clinical trials at McGill University’s Jewish General Hospital in Montreal, Canada. All aspects of the clinical trials in Canada will employ FDA standards at all levels. We estimate that the Pancreatic Cancer clinical trials will take approximately 18 to 24 months from start to finish. Given the terminal and limited treatment options available for the Pancreatic Cancer, we anticipate being granted limited marketing approval (“compassionate-use”) for our Adva-27a following a successful Phase I clinical trial. It is likely that following such events, we will begin to receive offers from large pharmaceutical companies to buyout or license our drug. Alternatively, it may be more advisable for us to continue our own development of the drug by proceeding to Phase II clinical trials and attending to other requirements for full marketing approval.”